Withings announced that its multi-function medical device BeamO has received clearance from the FDA. BeamO contains sensors to perform an electrocardiogram, a stethoscope and a thermometer. The company claims all three tests can be completed in less than a minute. It is now available for purchase and will retail for $250. The company unveiled BeamO at CES 2024. It's being positioned as a tool for telehealth, with a companion app that can send results to medical professionals. Withings is also offering a Cardio Check-Up service as part of its health subscription, where results from BeamO can be reviewed remotely by cardiologists who will deliver a cardiac health assessment to the device owner within 24 hours.Withings is the name behind several intriguing (and occasionally strange) [...]
Withings is at CES yet again, this year showing off its updated blood pressure monitor and a new way for its users to keep their hearts healthy. The Withings BPM Vision, for that is what it is called, [...]
Apple's Awe Dropping event started with dramatic health testimonials from Apple Watch users, then revealed a key new feature for the new Watch Series 11: hypertension alerts. The function had yet [...]
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]
Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical Devices regulation in the EU," making them officially rea [...]
Back in 2023, Withings launched Body Scan, a super-premium scale with the sort of tech found in a high-end gym or low-end clinic. It had a six-lead ECG, offered segmented body composition and could mo [...]